References
- Balogh, J.; Victor, D.; III, Asham, E. H.; Burroughs, S. G.; Boktour, M.; Saharia, A.; Li, X.; Ghobrial, R. M.; Monsour, H. P. Jr. Hepatocellular Carcinoma: A Review. J. Hepatocell. Carcinoma 2016, 3, 41–53. DOI: https://doi.org/10.2147/JHC.S61146.
- Singh, A. K.; Kumar, R.; Pandey, A. K. Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers. Curr. Chem. Genom. Transl. Med. 2018, 12, 9–26. DOI: https://doi.org/10.2174/2213988501812010009.
- Khan, M. A.; Raza, A.; Ovais, M.; Sohail, M. F.; Ali, S. Current State and Prospects of Nano-Delivery Systems for Sorafenib. International Journal of Polymeric Materials and Polymeric Biomaterials 2018, 67, 1105–1115. DOI: https://doi.org/10.1080/00914037.2018.1429434.
- Escudier, B.; Eisen, T.; Stadler, W. M.; Szczylik, C.; Oudard, S.; Siebels, M.; Negrier, S.; Chevreau, C.; Solska, E.; Desai, A. A.; et al. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma. N. Engl. J. Med. 2007, 356, 125–134. DOI: https://doi.org/10.1056/nejmx070012.
- Strumberg, D.; Richly, H.; Hilger, R. A.; Schleucher, N.; Korfee, S.; Tewes, M.; Faghih, M.; Brendel, E.; Voliotis, D.; Haase, C. G.; et al. Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor Bay 43-9006 in Patients with Advanced Refractory Solid Tumors. JCO. 2005, 23, 965–972. DOI: https://doi.org/10.1200/JCO.2005.06.124.
- Ratain, M. J.; Eisen, T.; Stadler, W. M.; Flaherty, K. T.; Kaye, S. B.; Rosner, G. L.; Gore, M.; Desai, A. A.; Patnaik, A.; Xiong, H. Q.; et al. Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients with Metastatic Renal Cell Carcinoma. J. Clin. Oncol. 2006, 24, 2505–2512. DOI: https://doi.org/10.1016/j.urolonc.2006.08.006.
- Llovet, J. M.; Ricci, S.; Mazzaferro, V.; Hilgard, P.; Gane, E.; Blanc, J.-F.; de Oliveira, A. C.; Santoro, A.; Raoul, J.-L.; Forner, A.; et al. Sorafenib in Advanced Hepatocellular Carcinoma. N. Engl. J. Med. 2008, 359, 378–390. DOI: https://doi.org/10.1056/NEJMoa0708857.
- Hotte, S.; Hirte, H. Bay 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies. Curr. Pharm. Des. 2002, 8, 2249–2253. DOI: https://doi.org/10.2174/1381612023393053.
- Clark, J. W.; Eder, J. P.; Ryan, D.; Lathia, C.; Lenz, H. J. Safety and Pharmacokinetics of the Dual Action Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor, Bay 43-9006, in Patients with Advanced, Refractory Solid Tumors. Clin. Cancer Res. 2005, 11, 5472–5480. DOI: https://doi.org/10.1158/1078-0432.ccr-04-2658.
- Daughton, C. G.; Ruhoy, I. S. Lower-Dose Prescribing: Minimizing "Side Effects" of Pharmaceuticals on Society and the Environment. Sci. Total Environ. 2013, 443, 324–337. DOI: https://doi.org/10.1016/j.scitotenv.2012.10.092.
- Pucci, C.; Martinelli, C.; Ciofani, G. Innovative Approaches for Cancer Treatment: Current Perspectives and New Challenges. Ecancermedicalscience 2019, 13, 96. Doi: https://doi.org/10.3332/ecancer.2019.961
- Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges. Nat. Rev. Cancer 2005, 5, 161–171. DOI: https://doi.org/10.1038/nrc1566.
- Guo, Y.; Zhong, T.; Duan, X. C.; Zhang, S.; Yao, X.; Yin, Y. F.; Huang, D.; Ren, W.; Zhang, Q.; Zhang, X. Improving Anti-Tumor Activity of Sorafenib Tosylate by Lipid- and Polymer-Coated Nanomatrix. Drug Deliv. 2017, 24, 270–277. DOI: https://doi.org/10.1080/10717544.2016.1245371.
- Wang, Q.; Ming Fan, X.; Ya-Ou Liu, J.; Zhao, B.; Jia, Z.-r.; Zhang, Q. Bioavailability and Pharmacokinetics of Sorafenib Suspension, Nanoparticles and Nanomatrix for Oral Administration to Rat. Int. J. Pharm. 2011, 419, 339–346. DOI: https://doi.org/10.1016/j.ijpharm.2011.08.003.
- Yang, P.; Qin, C.; Du, S.; Jia, J.; Qin, J.; Gong, J.; Wu, S. Crystal Structure, Stability and Desolvation of the Solvates of Sorafenib Tosylate. Crystals 2019, 9, 367. DOI: https://doi.org/10.3390/cryst9070367.
- Craparo, E. F.; Sardo, C.; Serio, R.; Zizzo, M. G.; Bondì, M. L.; Giammona, G.; Cavallaro, G. Galactosylated Polymeric Carriers for Liver Targeting of Sorafenib. Int. J. Pharm. 2014, 466, 172–180. DOI: https://doi.org/10.1016/j.ijpharm.2014.02.047.
- Truong, D. H.; Tran, T. H.; Ramasamy, T.; Choi, J. Y.; Choi, H. G.; Yong, C. S.; Kim, J. O. Preparation and Characterization of Solid Dispersion Using a Novel Amphiphilic Copolymer to Enhance Dissolution and Oral Bioavailability of Sorafenib. Powder Technol. 2015, 283, 260–265. DOI: https://doi.org/10.1016/j.powtec.2015.04.044.
- Zhang, Z.; Niu, B.; Chen, J.; He, X.; Bao, X.; Zhu, J.; Yu, H.; Li, Y. The Use of Lipid-Coated Nanodiamond to Improve Bioavailability and Efficacy of Sorafenib in Resisting Metastasis of Gastric Cancer. Biomaterials 2014, 35, 4565–4572. DOI: https://doi.org/10.1016/j.biomaterials.2014.02.024.
- Liu, C.; Chen, Z.; Chen, Y.; Lu, J.; Li, Y.; Wang, S.; Wu, G.; Qian, F. Improving Oral Bioavailability of Sorafenib by Optimizing the “"Spring" and "Parachute" Based on Molecular Interaction Mechanisms”. Mol. Pharm. 2016, 13, 599–608. https://doi.org/10.1021/acs.molpharmaceut.5b00837 DOI: https://doi.org/10.1021/acs.molpharmaceut.5b00837.
- Wang, Y.; Benzina, A.; Molin, D. G.; van den Akker, N.; Gagliardi, M.; Koole, L. H. Preparation and Structure of Drug-Carrying Biodegradable Microspheres Designed for Transarterial Chemoembolization Therapy. J. Biomater. Sci. Polym. Ed. 2015, 26, 77–91. DOI: https://doi.org/10.1080/09205063.2014.982242.
- Moni, S. S.; Alam, M. F.; Safhi, M. M.; Sultan, M. H.; Makeen, H. A.; Elmobark, M. E. Development of Formulation Methods and Physical Characterization of Injectable Sodium Selenite Nanoparticles for the Delivery of Sorafenib Tosylate. Curr. Pharm. Biotechnol. 2020, 21, 659–666. DOI: https://doi.org/10.2174/1389201021666191230124041.
- Poursaid, A.; Jensen, M. M.; Nourbakhsh, I.; Weisenberger, M.; Hellgeth, J. W.; Sampath, S.; Cappello, J.; Ghandehari, H. Silk-Elastinlike Protein Polymer Liquid Chemoembolic for Localized Release of Doxorubicin and Sorafenib. Mol. Pharm. 2016, 13, 2736–2748. DOI: https://doi.org/10.1021/acs.molpharmaceut.6b00325.
- Zhao, P.; Li, M.; Wang, Y.; Chen, Y.; He, C.; Zhang, X.; Yang, T.; Lu, Y.; You, J.; Lee, R. J.; et al. Enhancing Anti-Tumor Efficiency in Hepatocellular Carcinoma Through the Autophagy Inhibition by miR-375/Sorafenib in Lipid-Coated Calcium Carbonate Nanoparticles. Acta Biomater. 2018, 72, 248–255. DOI: https://doi.org/10.1016/j.actbio.2018.03.022.
- Kumar, R.; Santosh, T.; Yagnesh, N. S. Pharmaceutical Suspensions: Patient Compliance Oral Dosage Forms. World J. Pharmacy Pharmaceut. Sci. 2016, 7, 1471–1537.
- Chiou, W. L.; Riegelman, S. Pharmaceutical Applications of Solid Dispersion Systems. J. Pharm. Sci. 1971, 60, 1281–1302. https://doi.org/10.1002/jps.2600600902 DOI: https://doi.org/10.1002/jps.2600600902.
- Gupta, S.; Kesarla, R.; Omri, A. Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems. ISRN Pharm. 2013, 2013, 848043. https://doi.org/10.1155/2013/848043 DOI: https://doi.org/10.1155/2013/848043.
- Lengyel, M.; Kállai-Szabó, N.; Antal, V.; Laki, A. J.; Antal, I. Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery. Sci. Pharm. 2019, 87, 20. DOI: https://doi.org/10.3390/scipharm87030020.
- Lu, Y.; Park, K. Polymeric Micelles and Alternative Nanonized Delivery Vehicles for Poorly Soluble Drugs. Int. J. Pharm. 2013, 453, 198–214. DOI: https://doi.org/10.1016/j.ijpharm.2012.08.042.
- Pawar, C.; Bothiraja, C.; Shaikh, K.; Mali, A. An Insight into Cochleates, a Potential Drug Delivery System. RSC Adv. 2015, 5, 81188–81202. DOI: https://doi.org/10.1039/C5RA08550K.
- Thornton, S. J.; Wasan, K. M. The Reformulation of Amphotericin B for Oral Administration to Treat Systemic Fungal Infections and Visceral Leishmaniasis. Expert Opin. Drug Deliv. 2009, 6, 271–284. DOI: https://doi.org/10.1517/17425240902802861.
- Zarif, L. Drug Delivery by Lipid Cochleates. Methods Enzymol. 2005, 391, 314–329. DOI: https://doi.org/10.1016/s0076-6879(05. )91018-5
- Ud Din, F.; Zeb, A.; Shah, K. U. Development, In-Vitro and In-Vivo Evaluation of Ezetimibe-Loaded Solid Lipid Nanoparticles and Their Comparison with Marketed Product. J. Drug Deliv. Sci. Technol. 2019, 51, 583–590. DOI: https://doi.org/10.1016/j.jddst.2019.02.026.
- Din, F. U.; Choi, J. Y.; Kim, D. W.; Mustapha, O.; Kim, D. S.; Thapa, R. K.; Ku, S. K.; Youn, Y. S.; Oh, K. T.; Yong, C. S.; et al. Irinotecan-Encapsulated Double-Reverse Thermosensitive Nanocarrier System for Rectal Administration. Drug Deliv. 2017, 24, 502–510. DOI: https://doi.org/10.1080/10717544.2016.1272651.
- Din, F. U.; Kim, D. W.; Choi, J. Y.; Thapa, R. K.; Mustapha, O.; Kim, D. S.; Oh, Y.-K.; Ku, S. K.; Youn, Y. S.; Oh, K. T.; et al. Irinotecan-Loaded Double-Reversible Thermogel with Improved Antitumor Efficacy without Initial Burst Effect and Toxicity for Intramuscular Administration. Acta Biomater. 2017, 54, 239–248. https://doi.org/10.1016/j.actbio.2017.03.007 DOI: https://doi.org/10.1016/j.actbio.2017.03.007.
- Park, J. H.; Cho, J. H.; Kim, D. S.; Kim, J. S.; Din, F. U.; Kim, J. O.; Yong, C. S.; Youn, Y. S.; Oh, K. T.; Kim, D. W.; Choi, H. G. Revaprazan-Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and in Vivo Evaluation. Pharm. Dev. Technol. 2019, 24, 788–793. DOI: https://doi.org/10.1080/10837450.2019.1597114.
- Khaleeq, N.; Din, F. U.; Khan, A. S.; Rabia, S.; Dar, J.; Khan, G. M. Development of Levosulpiride-Loaded Solid Lipid Nanoparticles and Their In Vitro and In Vivo Comparison with Commercial Product. J. Microencapsul. 2020, 37, 160–169. DOI: https://doi.org/10.1080/02652048.2020.1713242.
- D’Souza, S. A Review of in Vitro Drug Release Test Methods for Nano-Sized Dosage Forms. Adv. Pharmaceut. 2014, 2014, 1–12. DOI: https://doi.org/10.1155/2014/304757.
- Hazra, R. S.; Kale, N.; Aland, G.; Qayyumi, B.; Mitra, D.; Jiang, L.; Bajwa, D.; Khandare, J.; Chaturvedi, P.; Quadir, M. Cellulose Mediated Transferrin Nanocages for Enumeration of Circulating Tumor Cells for Head and Neck Cancer. Sci. Rep. 2020, 10, 1–4. DOI: https://doi.org/10.1038/s41598-020-72920-9.
- Khutale, G. V.; Casey, A. Synthesis and Characterization of a Multifunctional Gold-Doxorubicin Nanoparticle System for pH Triggered Intracellular Anticancer Drug Release. Eur. J. Pharm. Biopharm. 2017, 119, 372–380. DOI: https://doi.org/10.1016/j.ejpb.2017.07.009.
- Evans, E.; Needham, D. Physical Properties of Surfactant Bilayer Membranes: Thermal Transitions, Elasticity, Rigidity, Cohesion and Colloidal Interactions. J. Phys. Chem. 1987, 91, 4219–4228. DOI: https://doi.org/10.1021/j100300a003.
- Ahiwale, R.; Chellampillai, B.; Pawar, A. Investigation of 1, 2-Dimyristoyl-sn-Glycero-3-Phosphoglycerol-Sodium (DMPG-Na) Lipid with Various Metal Cations in Nanocochleate Preformulation: Application for Andrographolide Oral Delivery in Cancer Therapy. AAPS PharmSciTech 2020, 21, 1–8. DOI: https://doi.org/10.1208/s12249-020-01801-1.
- Vogler, G. A. Anesthesia and Analgesia. In The Laboratory Rat. Suckow, M. A.; Weisbroth, S. H.; Franklin, C. L., Eds.; Academic Press: Cambridge, United States, 2006:627–664.
- Lee, M.; Young, K. S.; Kim, J.; Kim, H. S.; Kim, S. M.; Kim, E. J. Mitogen-Activated Protein Kinase Phosphatase-1 Inhibition and Sustained Extracellular Signal-Regulated Kinase 1/2 Activation in Camptothecin-Induced Human Colon Cancer Cell Death. Cancer Biol. Ther. 2013, 14, 1007–1015. DOI: https://doi.org/10.4161/cbt.26044.
- Zhang, Y.; Huo, M.; Zhou, J.; Xie, S. PKSolver: An Add-In Program for Pharmacokinetic and Pharmacodynamic Data Analysis in Microsoft Excel. Comput. Methods Programs Biomed. 2010, 99, 306–314. DOI: https://doi.org/10.1016/j.cmpb.2010.01.007.
- Mazard, T.; Causse, A.; Simony, J.; Leconet, W.; Vezzio-Vie, N.; Torro, A.; Jarlier, M.; Evrard, A.; Del Rio, M.; Assenat, E.; et al. Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump. Mol. Cancer Ther. 2013, 12, 2121–2134. DOI: https://doi.org/10.1158/1535-7163.mct-12-0966.
- Kakkar, P.; Das, B.; Viswanathan, P. N. A Modified Spectrophotometric Assay of Superoxide Dismutase. Indian Journal of Biochemistry and Biophysics, 1984, 21, 130–132.
- Sinha, A. K. Colorimetric Assay of Catalase. Anal. Biochem. 1972, 47, 389–394. DOI: https://doi.org/10.1016/0003-2697(72)90132-7
- Ellman, G. L. Tissue Sulfhydryl Groups. Arch. Biochem. Biophys. 1959, 82, 70–77. DOI: https://doi.org/10.1016/0003-9861(59)90090-6.
- Niehaus, W. G.; Samuelsson, B. Formation of Malonaldehyde from Phospholipid Arachidonate during Microsomal Lipid Peroxidation. Eur. J. Biochem. 1968, 6, 126–130. DOI: https://doi.org/10.1111/j.1432-1033.1968.tb00428.x.
- Banchroft, J. D.; Stevens, A.; Turner, D. R. Theory and Practice of Histological Techniques, Churchill Livingstone; Churchill Livingstone: London, 1996.
- Asprea, M.; Tatini, F.; Piazzini, V.; Rossi, F.; Bergonzi, M. C.; Bilia, A. R. Stable, Monodisperse, and Highly Cell-Permeating Nanocochleates from Natural Soy Lecithin Liposomes. Pharmaceutics 2019, 11, 34. DOI: https://doi.org/10.3390/pharmaceutics11010034.
- Sadeeshkumar, V.; Duraikannu, A.; Ravichandran, S.; Fredrick, W. S.; Sivaperumal, R.; Kodisundaram, P. Protective Effects of Dieckol on N-Nitrosodiethylamine Induced Hepatocarcinogenesis in Rats. Biomed. Pharmacother. 2016, 84, 1810–1819. DOI: https://doi.org/10.1016/j.biopha.2016.10.091.
- Devaux, P. F. Static and Dynamic Lipid Asymmetry in Cell Membranes. Biochemistry 1991, 30, 1163–1173. DOI: https://doi.org/10.1021/bi00219a001.
- Pons, M.; Foradada, M.; Estelrich, J. Liposomes Obtained by the Ethanol Injection Method. Int. J. Pharm. 1993, 95, 51–56. DOI: https://doi.org/10.1016/0378-5173(93)90389-W.
- Mousa, A. B. Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma. Saudi J. Gastroenterol. 2008, 14, 40. DOI: https://doi.org/10.4103/1319-3767.37808.
- Whittaker, S.; Marais, R.; Zhu, A. X. The Role of Signaling Pathways in the Development and Treatment of Hepatocellular Carcinoma. Oncogene 2010, 29, 4989–5005. DOI: https://doi.org/10.1038/onc.2010.236.
- Grossi, V.; Liuzzi, M.; Murzilli, S.; Martelli, N.; Napoli, A.; Ingravallo, G.; Rio, A. D.; Simone, C. Sorafenib Inhibits p38α Activity in Colorectal Cancer Cells and Synergizes with the DFG-in Inhibitor SB202190 to Increase Apoptotic Response. Cancer Biology & Therapy 2012, 13, 1471–1481. DOI: https://doi.org/10.4161/cbt.22254.
- Jaiswal, B. S.; Janakiraman, V.; Kljavin, N. M.; Eastham-Anderson, J.; Cupp, J. E.; Liang, Y.; Davis, D. P.; Hoeflich, K. P.; Seshagiri, S. Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways is Required for Efficacy in NRAS Mutant Tumors. PLoS One. 2009, 4, e5717. DOI: https://doi.org/10.1371/journal.pone.0005717.
- Ji, R. C. Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses. IJMS. 2016, 18, 51. DOI: https://doi.org/10.3390/ijms18010051.
- Bothiraja, C.; Yojana, B. D.; Pawar, A. P.; Shaikh, K. S.; Thorat, U. H. Fisetin-Loaded Nanocochleates: Formulation, Characterisation, In Vitro Anticancer Testing, Bioavailability and Biodistribution Study. Expert Opin. Drug Deliv. 2014, 11, 17–29. DOI: https://doi.org/10.1517/17425247.2013.860131.
- Chaudhary, S.; Garg, T.; Murthy, R. S. R.; Rath, G.; Goyal, A. K. Recent Approaches of Lipid-Based Delivery System for Lymphatic Targeting via Oral Route. J. Drug Target. 2014, 22, 871–882. DOI: https://doi.org/10.3109/1061186x.2014.950664.
- Sadek, K. M.; Abouzed, T. K.; Abouelkhair, R.; Nasr, S. The Chemo-Prophylactic Efficacy of an Ethanol Moringa Oleifera Leaf Extract against Hepatocellular Carcinoma in Rats. Pharm. Biol. 2017, 55, 1458–1466. DOI: https://doi.org/10.1080/13880209.2017.1306713.
- Aino, H.; Sumie, S.; Niizeki, T.; Kuromatsu, R.; Tajiri, N.; Nakano, M.; Satani, M.; Yamada, S.; Okamura, S.; Shimose, S.; et al. Clinical Characteristics and Prognostic Factors for Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis. Mol. Clin. Oncol. 2014, 2, 393–398. DOI: https://doi.org/10.3892/mco.2014.259.
- Connolly, G. C.; Khorana, A. A.; Kuderer, N. M.; Culakova, E.; Francis, C. W.; Lyman, G. H. Leukocytosis, Thrombosis and Early Mortality in Cancer Patients Initiating Chemotherapy. Thrombosis Res. 2010, 126, 113–118. DOI: https://doi.org/10.1016/j.thromres.2010.05.012.
- Xie, X.; Wang, L.; Yao, M.; Wen, X.; Chen, X.; You, H.; Jia, J.; Zhao, J.; Lu, F. Correlation between Red Blood Cell Count and Liver Function Status. Chinese J. Hepatol. 2016, 24, 119–12210. DOI: https://doi.org/10.3760/cma.j.issn.1007-3418.2016.02.009.
- Gkamprela, E.; Deutsch, M.; Pectasides, D. Iron Deficiency Anemia in Chronic Liver Disease: Etiopathogenesis, Diagnosis and Treatment. Ann. Gastroenterol. 2017, 30, 405–405. DOI: https://doi.org/10.20524/aog.2017.0152.
- Yoon, H. J.; Kim, K.; Nam, Y. S.; Yun, J. M.; Park, M. Mean Corpuscular Volume Levels and All-Cause and Liver Cancer Mortality. Clin. Chem. Lab. Med. (CCLM) 2016, 54, 1247–1257. DOI: https://doi.org/10.1515/cclm-2015-0786.
- Sarma, P. R. Red Cell Indices. In Clinical Methods: The History, Physical, and Laboratory Examinations, Walker, H. K.; Hall, W. D.; Hurst, J. W., Eds.; 3rd ed. Butterworths: Boston, United States, 1990.
- Carr, B. I.; Guerra, V. Thrombocytosis and Hepatocellular Carcinoma. Dig. Dis. Sci. 2013, 58, 1790–1796. DOI: https://doi.org/10.1007/s10620-012-2527-3.
- Grivennikov, S. I.; Greten, F. R.; Karin, M. Immunity, Inflammation, and Cancer. Cell 2010, 140, 883–899. DOI: https://doi.org/10.1016/j.cell.2010.01.025.
- Zhao, X.; Chen, Q.; Li, Y.; Tang, H.; Liu, W.; Yang, W. Doxorubicin and Curcumin Co-Delivery by Lipid Nanoparticles for Enhanced Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice. Eur. J. Pharm. Biopharm. 2015, 93, 27–36. DOI: https://doi.org/10.1016/j.ejpb.2015.03.003.
- Barcellini, W.; Fattizzo, B. Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia. Dis. Markers 2015, 2015, 635670–635677. doi:https://doi.org/10.1155/2015/635670 DOI: https://doi.org/10.1155/2015/635670.
- Kotoh, K.; Kato, M.; Kohjima, M.; Tanaka, M.; Miyazaki, M.; Nakamura, K.; Enjoji, M.; Nakamuta, M.; Takayanagi, R. Lactate Dehydrogenase Production in Hepatocytes is Increased at an Early Stage of Acute Liver Failure. Exp. Ther. Med. 2011, 2, 195–199. DOI: https://doi.org/10.3892/etm.2011.197.
- Kim, H.; Kim, Y.; Lee, J. Liposomal Formulations for Enhanced Lymphatic Drug Delivery. Asian J. Pharm. Sci. 2013, 8, 96–103. doi: https://doi.org/10.1016/j.ajps.2013.07.012 DOI: https://doi.org/10.1016/j.ajps.2013.07.012.
- Ighodaro, O. M.; Akinloye, O. A. First Line Defence Antioxidants-Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX): Their Fundamental Role in the Entire Antioxidant Defence Grid. Alexandria J. Med. 2018, 54, 287–293. DOI: https://doi.org/10.1016/j.ajme.2017.09.001.
- Sharma, P.; Jha, A. B.; Dubey, R. S.; Pessarakli, M. Reactive Oxygen Species, Oxidative Damage, and Antioxidative Defense Mechanism in Plants under Stressful Conditions. J. Bot. 2012, 2012, 1–26. DOI: https://doi.org/10.1155/2012/217037.
- Zhang, C.; Wang, N.; Xu, Y.; Tan, H. Y.; Li, S.; Feng, Y. Molecular Mechanisms Involved in Oxidative Stress-Associated Liver Injury Induced by Chinese Herbal Medicine: An Experimental Evidence-Based Literature Review and Network Pharmacology Study. IJMS. 2018, 19, 2745. doi: https://doi.org/10.3390/ijms19092745. DOI: https://doi.org/10.3390/ijms19092745.
- Ayala, A.; Muñoz, M. F.; Argüelles, S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxid. Med. Cell. Longev. 2014, 2014, 360438. https://doi.org/10.1155/2014/360438 DOI: https://doi.org/10.1155/2014/360438.
- Elsadek, B.; Mansour, A.; Saleem, T.; Warnecke, A.; Kratz, F. The Antitumor Activity of a Lactosaminated Albumin Conjugate of Doxorubicin in a Chemically Induced Hepatocellular Carcinoma Rat Model Compared to Sorafenib. Digest. Liver Dis. 2017, 49, 213–222. DOI: https://doi.org/10.1016/j.dld.2016.10.003.
- Kujawska, M.; Ewertowska, M.; Adamska, T.; Ignatowicz, E. W. A.; Flaczyk, E. W. A.; Przeor, M.; Kurpik, M.; Liebert, J. J. Protective Effect of Morus Alba Leaf Extract on N-Nitrosodiethylamine-Induced Hepatocarcinogenesis in Rats. In Vivo 2016, 30, 807–812. DOI: https://doi.org/10.21873/invivo.10998.
- Çoban, Ö.; Değim, Z.; Yılmaz, S.; Altıntaş, L.; Arsoy, T.; Sözmen, M. Efficacy of Targeted Liposomes and Nanocochleates Containing Imatinib plus Dexketoprofen against Fibrosarcoma. Drug Dev. Res. 2019, 80, 556–565. DOI: https://doi.org/10.1002/ddr.21530.
- Horng, C. T.; Huang, C. W.; Yang, M. Y.; Chen, T. H.; Chang, Y. C.; Wang, C. J. Nelumbo Nucifera Leaf Extract Treatment Attenuated Preneoplastic Lesions and Oxidative Stress in the Livers of Diethylnitrosamine-Treated Rats. Environ. Toxicol. 2017, 32, 2327–2340. DOI: https://doi.org/10.1002/tox.22434.
- Nadaf, S. J.; Killedar, S. G. Curcumin Nanocochleates: Use of Design of Experiments, Solid State Characterization, In Vitro Apoptosis and Cytotoxicity against Breast Cancer MCF-7 Cells. J. Drug Deliv. Sci. Technol. 2018, 47, 337–350. DOI: https://doi.org/10.1016/j.jddst.2018.06.026.
- Bhosale, R. R.; Gangadharappa, H. V.; Gowda, D. V.; Osmani, R. A. M.; Vaghela, R. A Review on Nanocochleates: The Inimitable Nanoparticulate Drug Carriers. Adv. Sci. Eng. Med. 2017, 9, 359–369. DOI: https://doi.org/10.1166/asem.2017.2020.
- Shende, P.; Khair, R.; Gaud, R. S. Nanostructured Cochleates: A Multi-Layered Platform for Cellular Transportation of Therapeutics. Drug Dev. Ind. Pharm. 2019, 45, 869–881. DOI: https://doi.org/10.1080/03639045.2019.1583757.
- Dixon, L. J.; Barnes, M.; Tang, H.; Pritchard, M. T.; Nagy, L. E. Kupffer Cells in the Liver. Compr. Physiol. 2013, 3, 785–797. https://doi.org/10.1002/cphy.c120026 DOI: https://doi.org/10.1002/cphy.c120026.
- Soji, T.; Murata, Y.; Ohira, A.; Nishizono, H.; Tanaka, M.; Herbert, D. C. Evidence that Hepatocytes Can Phagocytize Exogenous Substances. Anat. Rec. 1992, 233, 543–546. DOI: https://doi.org/10.1002/ar.1092330408.
- Poudel, I.; Ahiwale, R.; Pawar, A.; Mahadik, K.; Bothiraja, C. Development of Novel Biotinylated Chitosan-Decorated Docetaxel-Loaded Nanocochleates for Breast Cancer Targeting. Artif. Cells. Nanomed. Biotechnol. 2018, 46, 229–240. DOI: https://doi.org/10.1080/21691401.2018.1453831.
- Bothiraja, C.; Rajput, N.; Poudel, I.; Rajalakshmi, S.; Panda, B.; Pawar, A. Development of Novel Biofunctionalized Chitosan Decorated Nanocochleates as a Cancer Targeted Drug Delivery Platform. Artif. Cells. Nanomed. Biotechnol. 2018, 46, 447–461. https://doi.org/10.1080/21691401.2018.1430584 DOI: https://doi.org/10.1080/21691401.2018.1430584.